CervoMed Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CervoMed Inc. (CRVO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $362.27 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $362.27K, a 27.11% decline year-over-year.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $349.20K, a 3.31% decline year-over-year.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $298.74K, a 11.54% decline year-over-year.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $291.72K, a 7.56% increase year-over-year.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.45M, a 3.05% increase from fiscal 2024.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.41M, a 244.85% increase from fiscal 2023.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $407.63K, a 22.11% increase from fiscal 2022.
- CervoMed Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $333.83K, a 62.79% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $362.27K 10-Q · filed 2026-08-07 | $711.47K 10-Q · filed 2026-08-07 | $1.01M derived: sum of 3 quarters · filed 2026-08-07 | $1.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $349.20K 10-Q · filed 2026-05-15 | $647.93K derived: sum of 2 quarters · filed 2026-05-15 | $939.65K derived: sum of 3 quarters · filed 2026-05-15 | $1.44M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $298.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $590.45K derived: sum of 2 quarters · filed 2026-03-13 | $1.09M derived: sum of 3 quarters · filed 2026-08-07 | $1.45M 10-K · filed 2026-03-13 |
| 2025-09-30 | $291.72K 10-Q · filed 2025-11-07 | $788.73K derived: sum of 2 quarters · filed 2026-08-07 | $1.15M 10-Q · filed 2025-11-07 | $1.49M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $497.01K 10-Q · filed 2026-08-07 | $858.18K 10-Q · filed 2026-08-07 | $1.20M derived: sum of 3 quarters · filed 2026-08-07 | $1.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $361.17K 10-Q · filed 2026-05-15 | $698.88K derived: sum of 2 quarters · filed 2026-05-15 | $970.09K derived: sum of 3 quarters · filed 2026-05-15 | $1.55M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $337.71K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $608.93K derived: sum of 2 quarters · filed 2026-03-13 | $1.19M derived: sum of 3 quarters · filed 2026-03-13 | $1.41M 10-K · filed 2026-03-13 |
| 2024-09-30 | $271.21K 10-Q · filed 2024-11-12 | $849.80K derived: sum of 2 quarters · filed 2024-11-12 | $1.07M 10-Q · filed 2025-11-07 | $1.23M derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-06-30 | $578.58K 10-Q · filed 2024-08-09 | $796.80K 10-Q · filed 2025-08-08 | $961.77K derived: sum of 3 quarters · filed 2025-05-12 | $1.07M derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-03-31 | $218.22K 10-Q · filed 2025-05-12 | $383.19K derived: sum of 2 quarters · filed 2025-05-12 | $492.36K derived: sum of 3 quarters · filed 2025-05-12 | $554.61K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $164.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $274.14K derived: sum of 2 quarters · filed 2025-03-17 | $336.39K derived: sum of 3 quarters · filed 2025-03-17 | $407.63K 10-K · filed 2025-03-17 |
| 2023-09-30 | $109.17K 10-Q · filed 2024-11-12 | $171.42K derived: sum of 2 quarters · filed 2024-11-12 | $242.66K 10-Q · filed 2024-11-12 | $323.65K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $62.25K 10-Q · filed 2024-08-09 | $133.49K 10-Q · filed 2024-08-09 | $214.48K derived: sum of 3 quarters · filed 2024-08-09 | $296.86K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $71.24K 10-Q · filed 2024-05-14 | $152.23K derived: sum of 2 quarters · filed 2024-05-14 | $234.61K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | $80.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $163.37K derived: sum of 2 quarters · filed 2024-03-29 | $333.83K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $82.38K 10-Q · filed 2023-11-13 | $252.85K 10-Q · filed 2023-11-13 | ||
| 2021-12-31 | $254.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $418.70K derived: sum of 2 quarters · filed 2023-03-24 | $715.98K derived: sum of 3 quarters · filed 2023-03-24 | $897.26K 10-K · filed 2023-03-24 |
| 2021-09-30 | $164.39K 10-Q · filed 2022-11-14 | $461.67K derived: sum of 2 quarters · filed 2022-11-14 | $642.95K 10-Q · filed 2022-11-14 | $794.77K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $297.28K 10-Q · filed 2022-08-12 | $478.56K 10-Q · filed 2022-08-12 | $630.38K derived: sum of 3 quarters · filed 2022-08-12 | $909.86K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $181.28K 10-Q · filed 2022-05-12 | $333.10K derived: sum of 2 quarters · filed 2022-05-12 | $612.58K derived: sum of 3 quarters · filed 2022-05-12 | $726.02K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $151.82K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $431.30K derived: sum of 2 quarters · filed 2022-03-18 | $544.74K derived: sum of 3 quarters · filed 2022-03-18 | $736.12K 10-K · filed 2022-03-18 |
| 2020-09-30 | $279.47K 10-Q · filed 2021-11-10 | $392.92K derived: sum of 2 quarters · filed 2021-11-10 | $584.30K 10-Q · filed 2021-11-10 | $714.45K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $113.44K 10-Q · filed 2021-08-11 | $304.82K 10-Q · filed 2021-08-11 | $434.98K derived: sum of 3 quarters · filed 2021-08-11 | $580.30K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $191.38K 10-Q · filed 2021-05-07 | $321.54K derived: sum of 2 quarters · filed 2021-05-07 | $466.86K derived: sum of 3 quarters · filed 2021-05-07 | $615.94K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $130.16K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $275.48K derived: sum of 2 quarters · filed 2021-03-17 | $424.56K derived: sum of 3 quarters · filed 2021-03-17 | $515.76K 10-K · filed 2021-03-17 |
| 2019-09-30 | $145.32K 10-Q · filed 2020-11-12 | $294.40K derived: sum of 2 quarters · filed 2020-11-12 | $385.61K 10-Q · filed 2020-11-12 | $635.36K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $149.08K 10-Q · filed 2020-08-07 | $240.28K 10-Q · filed 2020-08-07 | $490.04K derived: sum of 3 quarters · filed 2020-08-07 | $817.44K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $91.20K 10-Q · filed 2020-05-11 | $340.96K derived: sum of 2 quarters · filed 2020-05-11 | $668.36K derived: sum of 3 quarters · filed 2020-05-11 | $988.13K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $249.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $577.15K derived: sum of 2 quarters · filed 2020-03-17 | $896.92K derived: sum of 3 quarters · filed 2020-03-17 | $1.22M 10-K · filed 2020-03-17 |
| 2018-09-30 | $327.40K 10-Q · filed 2019-11-08 | $647.16K derived: sum of 2 quarters · filed 2019-11-08 | $971.83K 10-Q · filed 2019-11-08 | $1.24M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $319.77K 10-Q · filed 2019-08-08 | $644.44K 10-Q · filed 2018-08-10 | $911.04K derived: sum of 3 quarters · filed 2019-08-08 | $1.20M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $324.67K 10-Q · filed 2019-08-08 | $591.27K derived: sum of 2 quarters · filed 2019-08-08 | $883.77K derived: sum of 3 quarters · filed 2019-08-08 | $1.20M derived: sum of 4 quarters · filed 2019-08-08 |
| 2017-12-31 | $266.60K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $559.10K derived: sum of 2 quarters · filed 2019-03-19 | $874.17K derived: sum of 3 quarters · filed 2019-03-19 | $1.24M 10-K · filed 2019-03-19 |
| 2017-09-30 | $292.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $607.57K derived: sum of 2 quarters · filed 2017-11-13 | $973.95K 10-Q · filed 2017-11-13 | $1.24M derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-06-30 | $315.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $681.45K 10-Q · filed 2017-08-14 | $950.53K derived: sum of 3 quarters · filed 2018-04-02 | $1.34M derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-03-31 | $366.38K 10-Q · filed 2017-05-15 | $635.46K derived: sum of 2 quarters · filed 2018-04-02 | $1.03M derived: sum of 3 quarters · filed 2018-04-02 | $1.36M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-12-31 | $269.08K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $659.43K derived: sum of 2 quarters · filed 2018-04-02 | $997.60K derived: sum of 3 quarters · filed 2018-04-02 | $1.39M 10-K · filed 2018-04-02 |
| 2016-09-30 | $390.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $728.52K derived: sum of 2 quarters · filed 2016-11-14 | $1.12M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $338.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $731.63K 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $393.47K 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | $594.17K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |